Recent development in therapeutics for breakthrough pain-Reference-Cited by-同舟云学术

Recent development in therapeutics for breakthrough pain

Published:2010-05 Issue:5 Volume:10 Page:757-773
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Davis Mellar P

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.1586/ern.10.41

Reference140 articles.

1. Portenoy RK, Forbes K, Lussier Det al.Difficult pain problems: an integrated approach. In:Oxford Textbook of Palliative Medicine 3rdEdition. Doyle D, Hanks G, Cherny N, Calman K (Eds). Oxford University Press, Oxford, UK 438–458 (2004).

2. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland

3. Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain

4. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.

5. Episodic (breakthrough) pain

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Pain in the Cancer Patient;JNCI Monographs;2019-08-01

2. Pain Management on the Battlefield;Handbook of Pain and Palliative Care;2018

3. The Role of Palliative Care in Lung Cancer;IASLC Thoracic Oncology;2018

4. Advances in Device and Formulation Technologies for Pulmonary Drug Delivery;AAPS PharmSciTech;2014-04-12

5. Nociception and inflammatory hyperalgesia evaluated in rodents using infrared laser stimulation after Trpv1 gene knockout or resiniferatoxin lesion;Pain;2014-04